These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cell type-specific transcriptional enhancement in vitro requires the presence of trans-acting factors.
    Author: Schöler HR, Gruss P.
    Journal: EMBO J; 1985 Nov; 4(11):3005-13. PubMed ID: 2998773.
    Abstract:
    Cell-specific transcriptional enhancement was observed, depending on the enhancer sequences, using nuclear extracts prepared from B-cells, T-cells and HeLa cells. SV40 enhancer stimulated in vitro transcription up to 15-fold in all three cell extracts, whereas transcriptional potentiation in vitro by IgC mu and LPV enhancers was only seen in B- and T-cell extracts. Thus, the cell type specificity seen in vivo can be reproduced in vitro. The transcriptional enhancement requires the presence of enhancer sequences in cis and also of a common factor interacting in trans with all three enhancer sequences. Interestingly, first experiments indicate the additional presence of cellular factors in T-cell and most prominently in HeLa cell extracts which can reduce the enhancer activity of C mu and LPV.
    [Abstract] [Full Text] [Related] [New Search]